Results 311 to 320 of about 444,858 (389)

A starch hydrolysis procedure to estimate glycemic index

, 1997
I. Goñi, A. García-Alonso, F. Saura-calixto   +2 more
semanticscholar   +1 more source

Impact of CYP2C19 Genotype Variants on PCSK9 Inhibitor Efficacy in Lipid‐Lowering Among Patients With Symptomatic Intracranial Atherosclerotic Stenosis

Lipids, EarlyView.
ABSTRACT Ischemic stroke is frequently associated with symptomatic intracranial atherosclerotic stenosis (sICAS), is a leading cause of global disability and mortality. Current guidelines recommend dual antiplatelet and intensive statin therapies. Proprotein convertase subtilisin 9/kexin type 9 (PCSK9) inhibitors have emerged as a potent lipid‐lowering
Chao Zhao, Nuan Wang, Di Shi, Hao Zhou, Dan Chen, Guofang Chen   +5 more
wiley   +1 more source

Association between carbohydrate quality and glycemic control in individuals with type 1 diabetes: A cross-sectional and meal-based analysis. [PDF]

PLoS One
Bian L, Yang C, Jin Y, Wang H, Zhu M, Xu J, Bai J, Zhang M, Liu Y, Yang T, Gu Y, Liu H.   +11 more
europepmc   +1 more source

Evaluation of the efectiveness of a protocol designed to improve glycemic control in patients with hyperglycemia

, 2016
Jordi Esteban, María Dolores Ollero García-Agulló, Ana Iriarte Beroiz, José Javier Pineda Arribas   +3 more
openalex   +1 more source

Diabetic Peripheral Neuropathy: Molecular Staging, Risk Factors, Therapeutics, and Emerging Trends

Med Research, EarlyView.
The heterogeneous landscape of DPN can be unified through a tripartite pathogenic model encompassing progressive stages of metabolic dysregulation, chronic inflammation, and overt neuronal damage. Within this framework, six clinical subtypes were identified, namely, hyperglycemia‐driven, dyslipidemia‐driven, inflammation‐driven, dysvascularity‐driven ...
Xiaofeng Dai, Mingze Tang
wiley   +1 more source

Impacts of insulin storage and injection techniques intervention on glycemic control among patients with diabetes in northwest Ethiopia: a quasi-experimental study. [PDF]

Ther Adv Endocrinol Metab
Dagnew SB, Zewdu WS, Wondm SA, Moges TA, Dagnew FN, Anberbr SS, Tarekegn GY, Zerihun TE, Mussie DA, Kassaw AT, Azenega AS, Melese TB, Dagnaw GB, Mebrat MW, Zeleke TK, Yazie TS.   +15 more
europepmc   +1 more source

When the Scale Drops: Pathways to Weight Loss in Parkinson's Disease and Future Directions

Movement Disorders, EarlyView.
Abstract Although Parkinson's disease (PD) is classically defined by its motor features, non‐motor symptoms exert a substantial and often under‐recognized influence on disease trajectory. Among these, weight loss has long been observed in PD and other neurodegenerative disorders, yet the mechanisms remain incompletely understood.
Ellie D. Gabriel, Robert S. Eisinger, Joyce M. Lee, Sarah Hamimi, Hope Kim, Susanna D. Howard, Casey H. Halpern   +6 more
wiley   +1 more source

Physiological Advantages of a Fiber-Enriched Plant-Based Dessert: Improved Glycemic Control and Appetite Regulation over a Commercial Dairy Product. [PDF]

ACS Omega
Pereira MTL, de Aquino AC, Porro C, Frota Gaban SV.   +3 more
europepmc   +1 more source

Time Dependent Propulsion Model of Hyperglycemia: A Vulnerability–Acceleration Framework for Glycemic Escalation

Aditya Aditya
openalex   +1 more source

Correlation Between Gut Microbiota, Metabolites, and Diabetic Complications: A Two‐Sample Mendelian Randomization Study

Medicine Advances, EarlyView.
Fang et al. demonstrate a significant causal relationship among gut microbiota, gut metabolites, and diabetic complications, highlighting a biological link underlying mechanisms of diabetic vascular diseases. These findings provide important implications for future therapeutic strategy and risk prediction.
Jiaxi Fang, Leilei Zhai, Chan Huang, Liqin Li, Yong Wang, Jiaojiao Fan, Wei Zhou   +6 more
wiley   +1 more source